143 related articles for article (PubMed ID: 36877259)
21. The bionic pancreas: novel perspectives on insulin replacement therapies.
Denecke C
Transplantation; 2015 Feb; 99(2):268-9. PubMed ID: 25651115
[No Abstract] [Full Text] [Related]
22. Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.
Majdpour D; Tsoukas MA; Yale JF; El Fathi A; Rutkowski J; Rene J; Garfield N; Legault L; Haidar A
Can J Diabetes; 2021 Dec; 45(8):734-742. PubMed ID: 33888413
[TBL] [Abstract][Full Text] [Related]
23. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
Sala-Mira I; Garcia P; Díez JL; Bondia J
Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
[TBL] [Abstract][Full Text] [Related]
24. Development and Future of Automated Insulin Delivery (AID) Systems.
Garg SK; McVean JJ
Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
[No Abstract] [Full Text] [Related]
25. Fully Closed Loop Glucose Control With a Bihormonal Artificial Pancreas in Adults With Type 1 Diabetes: An Outpatient, Randomized, Crossover Trial.
Blauw H; Onvlee AJ; Klaassen M; van Bon AC; DeVries JH
Diabetes Care; 2021 Mar; 44(3):836-838. PubMed ID: 33397767
[TBL] [Abstract][Full Text] [Related]
26. Long-term use of the hybrid artificial pancreas by adjusting carbohydrate ratios and programmed basal rate: A reinforcement learning approach.
Jafar A; Fathi AE; Haidar A
Comput Methods Programs Biomed; 2021 Mar; 200():105936. PubMed ID: 33515844
[TBL] [Abstract][Full Text] [Related]
27. Testing the Real-World Accuracy of the Dexcom G6 Pro CGM During the Insulin-Only Bionic Pancreas Pivotal Trial.
Marak MC; Calhoun P; Damiano ER; Russell SJ; Ruedy KJ; Beck RW
Diabetes Technol Ther; 2023 Nov; 25(11):817-821. PubMed ID: 37668666
[TBL] [Abstract][Full Text] [Related]
28. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
[TBL] [Abstract][Full Text] [Related]
29. Bionic Pancreas Outperforms Standard Care for Type 1 Diabetes in Trial.
Larkin HD
JAMA; 2022 Nov; 328(18):1798-1799. PubMed ID: 36346424
[No Abstract] [Full Text] [Related]
30. Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4.
Pinsker JE; Dassau E; Deshpande S; Raghinaru D; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Church MM; Desrochers H; Ekhlaspour L; Kaur RJ; Levister C; Shi D; Lum JW; Kollman C; Doyle FJ;
Diabetes Technol Ther; 2022 Sep; 24(9):635-642. PubMed ID: 35549708
[No Abstract] [Full Text] [Related]
31. Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas.
Howard KR; Garza KP; Feldman M; Weissberg-Benchell J
J Pediatr Psychol; 2024 Jun; 49(6):413-420. PubMed ID: 38591792
[TBL] [Abstract][Full Text] [Related]
32. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
[No Abstract] [Full Text] [Related]
33. Changes in Ambulatory Glucose Profile in Patients With Type 1 Diabetes Mellitus After Switching From Sensor-Augmented Insulin Pump Therapy to a Do-It-Yourself Artificial Pancreas System: A Retrospective Data Analysis of Real-World Data.
Müller-Korbsch M; Frühwald L; Kietaibl A
J Diabetes Sci Technol; 2022 Nov; 16(6):1577-1579. PubMed ID: 35915931
[No Abstract] [Full Text] [Related]
34. Nocturnal glucose control with an artificial pancreas at a diabetes camp.
Phillip M; Battelino T; Atlas E; Kordonouri O; Bratina N; Miller S; Biester T; Stefanija MA; Muller I; Nimri R; Danne T
N Engl J Med; 2013 Feb; 368(9):824-33. PubMed ID: 23445093
[TBL] [Abstract][Full Text] [Related]
35. Comparison Between Closed-Loop Insulin Delivery System (the Artificial Pancreas) and Sensor-Augmented Pump Therapy: A Randomized-Controlled Crossover Trial.
Haidar A; Legault L; Raffray M; Gouchie-Provencher N; Jacobs PG; El-Fathi A; Rutkowski J; Messier V; Rabasa-Lhoret R
Diabetes Technol Ther; 2021 Mar; 23(3):168-174. PubMed ID: 33050728
[No Abstract] [Full Text] [Related]
36. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
[TBL] [Abstract][Full Text] [Related]
37. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
[TBL] [Abstract][Full Text] [Related]
38. A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Haidar A; Tsoukas MA; Bernier-Twardy S; Yale JF; Rutkowski J; Bossy A; Pytka E; El Fathi A; Strauss N; Legault L
Diabetes Care; 2020 Mar; 43(3):597-606. PubMed ID: 31974099
[TBL] [Abstract][Full Text] [Related]
39. Decreasing the Burden of Carbohydrate Counting and Meal Announcement with Automated Insulin Delivery, Meal Recognition, and Autocorrection Doses: A Case Study.
Buckingham BA; Bergenstal RM
Diabetes Technol Ther; 2024 Mar; 26(S3):97-101. PubMed ID: 38377320
[TBL] [Abstract][Full Text] [Related]
40. NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption.
Aaron RE; Tian T; Yeung AM; Huang J; Arreaza-Rubín GA; Ginsberg BH; Kompala T; Lee WA; Kerr D; Colmegna P; Mendez CE; Muchmore DB; Wallia A; Klonoff DC
J Diabetes Sci Technol; 2024 Jan; 18(1):215-239. PubMed ID: 37811866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
